Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)

Hongyun Huang, Wise Young, Lin Chen, Shiqing Feng, Ziad M.Al Zoubi, Hari Shanker Sharma, Hooshang Saberi, Gustavo A. Moviglia, Xijing He, Dafin F. Muresanu, Alok Sharma, Ali Otom, Russell J. Andrews, Adeeb Al-Zoubi, Andrey S. Bryukhovetskiy, Elena R. Chernykh, Krystyna Domańska-Janik, Emad Jafar, W. Eustace Johnson, Ying LiDaqing Li, Zuo Luan, Gengsheng Mao, Ashok K. Shetty, Dario Siniscalco, Stephen Skaper, Tiansheng Sun, Yunliang Wang, Lars Wiklund, Qun Xue, Si Wei You, Zuncheng Zheng, Milan R. Dimitrijevic, W. S.El Masri, Paul R. Sanberg, Qunyuan Xu, Guoming Luan, Michael Chopp, Kyoung Suok Cho, Xin Fu Zhou, Ping Wu, Kai Liu, Hamid Mobasheri, Seiji Ohtori, Hiroyuki Tanaka, Fabin Han, Yaping Feng, Shaocheng Zhang, Yingjie Lu, Zhicheng Zhang, Yaojian Rao, Zhouping Tang, Haitao Xi, Liang Wu, Shunji Shen, Mengzhou Xue, Guanghong Xiang, Xiaoling Guo, Xiaofeng Yang, Yujun Hao, Yong Hu, Jinfeng Li, Qiang Ao, Bin Wang, Zhiwen Zhang, Ming Lu, Tong Li

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cell therapy has been shown to be a key clinical therapeutic option for central nervous system diseases or damage. Standardization of clinical cell therapy procedures is an important task for professional associations devoted to cell therapy. The Chinese Branch of the International Association of Neurorestoratology (IANR) completed the first set of guidelines governing the clinical application of neurorestoration in 2011. The IANR and the Chinese Association of Neurorestoratology (CANR) collaborated to propose the current version “Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)”. The IANR council board members and CANR committee members approved this proposal on September 1, 2016, and recommend it to clinical practitioners of cellular therapy. These guidelines include items of cell type nomenclature, cell quality control, minimal suggested cell doses, patient-informed consent, indications for undergoing cell therapy, contraindications for undergoing cell therapy, documentation of procedure and therapy, safety evaluation, efficacy evaluation, policy of repeated treatments, do not charge patients for unproven therapies, basic principles of cell therapy, and publishing responsibility.

Original languageEnglish (US)
Pages (from-to)310-324
Number of pages15
JournalCell Transplantation
Volume27
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

Neurology
Terminology
Cell- and Tissue-Based Therapy
Standardization
Quality control
Guidelines
Committee Membership
Therapeutics
Central Nervous System Diseases
Informed Consent
Quality Control
Documentation
Safety

Keywords

  • cell therapy
  • clinical application guideline neurorestoratology
  • neurorestoration

ASJC Scopus subject areas

  • Biomedical Engineering
  • Cell Biology
  • Transplantation

Cite this

Huang, H., Young, W., Chen, L., Feng, S., Zoubi, Z. M. A., Sharma, H. S., ... Li, T. (2018). Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017). Cell Transplantation, 27(2), 310-324. https://doi.org/10.1177/0963689717746999

Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017). / Huang, Hongyun; Young, Wise; Chen, Lin; Feng, Shiqing; Zoubi, Ziad M.Al; Sharma, Hari Shanker; Saberi, Hooshang; Moviglia, Gustavo A.; He, Xijing; Muresanu, Dafin F.; Sharma, Alok; Otom, Ali; Andrews, Russell J.; Al-Zoubi, Adeeb; Bryukhovetskiy, Andrey S.; Chernykh, Elena R.; Domańska-Janik, Krystyna; Jafar, Emad; Johnson, W. Eustace; Li, Ying; Li, Daqing; Luan, Zuo; Mao, Gengsheng; Shetty, Ashok K.; Siniscalco, Dario; Skaper, Stephen; Sun, Tiansheng; Wang, Yunliang; Wiklund, Lars; Xue, Qun; You, Si Wei; Zheng, Zuncheng; Dimitrijevic, Milan R.; Masri, W. S.El; Sanberg, Paul R.; Xu, Qunyuan; Luan, Guoming; Chopp, Michael; Cho, Kyoung Suok; Zhou, Xin Fu; Wu, Ping; Liu, Kai; Mobasheri, Hamid; Ohtori, Seiji; Tanaka, Hiroyuki; Han, Fabin; Feng, Yaping; Zhang, Shaocheng; Lu, Yingjie; Zhang, Zhicheng; Rao, Yaojian; Tang, Zhouping; Xi, Haitao; Wu, Liang; Shen, Shunji; Xue, Mengzhou; Xiang, Guanghong; Guo, Xiaoling; Yang, Xiaofeng; Hao, Yujun; Hu, Yong; Li, Jinfeng; Ao, Qiang; Wang, Bin; Zhang, Zhiwen; Lu, Ming; Li, Tong.

In: Cell Transplantation, Vol. 27, No. 2, 01.02.2018, p. 310-324.

Research output: Contribution to journalArticle

Huang, H, Young, W, Chen, L, Feng, S, Zoubi, ZMA, Sharma, HS, Saberi, H, Moviglia, GA, He, X, Muresanu, DF, Sharma, A, Otom, A, Andrews, RJ, Al-Zoubi, A, Bryukhovetskiy, AS, Chernykh, ER, Domańska-Janik, K, Jafar, E, Johnson, WE, Li, Y, Li, D, Luan, Z, Mao, G, Shetty, AK, Siniscalco, D, Skaper, S, Sun, T, Wang, Y, Wiklund, L, Xue, Q, You, SW, Zheng, Z, Dimitrijevic, MR, Masri, WSE, Sanberg, PR, Xu, Q, Luan, G, Chopp, M, Cho, KS, Zhou, XF, Wu, P, Liu, K, Mobasheri, H, Ohtori, S, Tanaka, H, Han, F, Feng, Y, Zhang, S, Lu, Y, Zhang, Z, Rao, Y, Tang, Z, Xi, H, Wu, L, Shen, S, Xue, M, Xiang, G, Guo, X, Yang, X, Hao, Y, Hu, Y, Li, J, Ao, Q, Wang, B, Zhang, Z, Lu, M & Li, T 2018, 'Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)', Cell Transplantation, vol. 27, no. 2, pp. 310-324. https://doi.org/10.1177/0963689717746999
Huang H, Young W, Chen L, Feng S, Zoubi ZMA, Sharma HS et al. Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017). Cell Transplantation. 2018 Feb 1;27(2):310-324. https://doi.org/10.1177/0963689717746999
Huang, Hongyun ; Young, Wise ; Chen, Lin ; Feng, Shiqing ; Zoubi, Ziad M.Al ; Sharma, Hari Shanker ; Saberi, Hooshang ; Moviglia, Gustavo A. ; He, Xijing ; Muresanu, Dafin F. ; Sharma, Alok ; Otom, Ali ; Andrews, Russell J. ; Al-Zoubi, Adeeb ; Bryukhovetskiy, Andrey S. ; Chernykh, Elena R. ; Domańska-Janik, Krystyna ; Jafar, Emad ; Johnson, W. Eustace ; Li, Ying ; Li, Daqing ; Luan, Zuo ; Mao, Gengsheng ; Shetty, Ashok K. ; Siniscalco, Dario ; Skaper, Stephen ; Sun, Tiansheng ; Wang, Yunliang ; Wiklund, Lars ; Xue, Qun ; You, Si Wei ; Zheng, Zuncheng ; Dimitrijevic, Milan R. ; Masri, W. S.El ; Sanberg, Paul R. ; Xu, Qunyuan ; Luan, Guoming ; Chopp, Michael ; Cho, Kyoung Suok ; Zhou, Xin Fu ; Wu, Ping ; Liu, Kai ; Mobasheri, Hamid ; Ohtori, Seiji ; Tanaka, Hiroyuki ; Han, Fabin ; Feng, Yaping ; Zhang, Shaocheng ; Lu, Yingjie ; Zhang, Zhicheng ; Rao, Yaojian ; Tang, Zhouping ; Xi, Haitao ; Wu, Liang ; Shen, Shunji ; Xue, Mengzhou ; Xiang, Guanghong ; Guo, Xiaoling ; Yang, Xiaofeng ; Hao, Yujun ; Hu, Yong ; Li, Jinfeng ; Ao, Qiang ; Wang, Bin ; Zhang, Zhiwen ; Lu, Ming ; Li, Tong. / Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017). In: Cell Transplantation. 2018 ; Vol. 27, No. 2. pp. 310-324.
@article{54f91e1c610e4d2b8691184f4f72895f,
title = "Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)",
abstract = "Cell therapy has been shown to be a key clinical therapeutic option for central nervous system diseases or damage. Standardization of clinical cell therapy procedures is an important task for professional associations devoted to cell therapy. The Chinese Branch of the International Association of Neurorestoratology (IANR) completed the first set of guidelines governing the clinical application of neurorestoration in 2011. The IANR and the Chinese Association of Neurorestoratology (CANR) collaborated to propose the current version “Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)”. The IANR council board members and CANR committee members approved this proposal on September 1, 2016, and recommend it to clinical practitioners of cellular therapy. These guidelines include items of cell type nomenclature, cell quality control, minimal suggested cell doses, patient-informed consent, indications for undergoing cell therapy, contraindications for undergoing cell therapy, documentation of procedure and therapy, safety evaluation, efficacy evaluation, policy of repeated treatments, do not charge patients for unproven therapies, basic principles of cell therapy, and publishing responsibility.",
keywords = "cell therapy, clinical application guideline neurorestoratology, neurorestoration",
author = "Hongyun Huang and Wise Young and Lin Chen and Shiqing Feng and Zoubi, {Ziad M.Al} and Sharma, {Hari Shanker} and Hooshang Saberi and Moviglia, {Gustavo A.} and Xijing He and Muresanu, {Dafin F.} and Alok Sharma and Ali Otom and Andrews, {Russell J.} and Adeeb Al-Zoubi and Bryukhovetskiy, {Andrey S.} and Chernykh, {Elena R.} and Krystyna Domańska-Janik and Emad Jafar and Johnson, {W. Eustace} and Ying Li and Daqing Li and Zuo Luan and Gengsheng Mao and Shetty, {Ashok K.} and Dario Siniscalco and Stephen Skaper and Tiansheng Sun and Yunliang Wang and Lars Wiklund and Qun Xue and You, {Si Wei} and Zuncheng Zheng and Dimitrijevic, {Milan R.} and Masri, {W. S.El} and Sanberg, {Paul R.} and Qunyuan Xu and Guoming Luan and Michael Chopp and Cho, {Kyoung Suok} and Zhou, {Xin Fu} and Ping Wu and Kai Liu and Hamid Mobasheri and Seiji Ohtori and Hiroyuki Tanaka and Fabin Han and Yaping Feng and Shaocheng Zhang and Yingjie Lu and Zhicheng Zhang and Yaojian Rao and Zhouping Tang and Haitao Xi and Liang Wu and Shunji Shen and Mengzhou Xue and Guanghong Xiang and Xiaoling Guo and Xiaofeng Yang and Yujun Hao and Yong Hu and Jinfeng Li and Qiang Ao and Bin Wang and Zhiwen Zhang and Ming Lu and Tong Li",
year = "2018",
month = "2",
day = "1",
doi = "10.1177/0963689717746999",
language = "English (US)",
volume = "27",
pages = "310--324",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "2",

}

TY - JOUR

T1 - Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)

AU - Huang, Hongyun

AU - Young, Wise

AU - Chen, Lin

AU - Feng, Shiqing

AU - Zoubi, Ziad M.Al

AU - Sharma, Hari Shanker

AU - Saberi, Hooshang

AU - Moviglia, Gustavo A.

AU - He, Xijing

AU - Muresanu, Dafin F.

AU - Sharma, Alok

AU - Otom, Ali

AU - Andrews, Russell J.

AU - Al-Zoubi, Adeeb

AU - Bryukhovetskiy, Andrey S.

AU - Chernykh, Elena R.

AU - Domańska-Janik, Krystyna

AU - Jafar, Emad

AU - Johnson, W. Eustace

AU - Li, Ying

AU - Li, Daqing

AU - Luan, Zuo

AU - Mao, Gengsheng

AU - Shetty, Ashok K.

AU - Siniscalco, Dario

AU - Skaper, Stephen

AU - Sun, Tiansheng

AU - Wang, Yunliang

AU - Wiklund, Lars

AU - Xue, Qun

AU - You, Si Wei

AU - Zheng, Zuncheng

AU - Dimitrijevic, Milan R.

AU - Masri, W. S.El

AU - Sanberg, Paul R.

AU - Xu, Qunyuan

AU - Luan, Guoming

AU - Chopp, Michael

AU - Cho, Kyoung Suok

AU - Zhou, Xin Fu

AU - Wu, Ping

AU - Liu, Kai

AU - Mobasheri, Hamid

AU - Ohtori, Seiji

AU - Tanaka, Hiroyuki

AU - Han, Fabin

AU - Feng, Yaping

AU - Zhang, Shaocheng

AU - Lu, Yingjie

AU - Zhang, Zhicheng

AU - Rao, Yaojian

AU - Tang, Zhouping

AU - Xi, Haitao

AU - Wu, Liang

AU - Shen, Shunji

AU - Xue, Mengzhou

AU - Xiang, Guanghong

AU - Guo, Xiaoling

AU - Yang, Xiaofeng

AU - Hao, Yujun

AU - Hu, Yong

AU - Li, Jinfeng

AU - Ao, Qiang

AU - Wang, Bin

AU - Zhang, Zhiwen

AU - Lu, Ming

AU - Li, Tong

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Cell therapy has been shown to be a key clinical therapeutic option for central nervous system diseases or damage. Standardization of clinical cell therapy procedures is an important task for professional associations devoted to cell therapy. The Chinese Branch of the International Association of Neurorestoratology (IANR) completed the first set of guidelines governing the clinical application of neurorestoration in 2011. The IANR and the Chinese Association of Neurorestoratology (CANR) collaborated to propose the current version “Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)”. The IANR council board members and CANR committee members approved this proposal on September 1, 2016, and recommend it to clinical practitioners of cellular therapy. These guidelines include items of cell type nomenclature, cell quality control, minimal suggested cell doses, patient-informed consent, indications for undergoing cell therapy, contraindications for undergoing cell therapy, documentation of procedure and therapy, safety evaluation, efficacy evaluation, policy of repeated treatments, do not charge patients for unproven therapies, basic principles of cell therapy, and publishing responsibility.

AB - Cell therapy has been shown to be a key clinical therapeutic option for central nervous system diseases or damage. Standardization of clinical cell therapy procedures is an important task for professional associations devoted to cell therapy. The Chinese Branch of the International Association of Neurorestoratology (IANR) completed the first set of guidelines governing the clinical application of neurorestoration in 2011. The IANR and the Chinese Association of Neurorestoratology (CANR) collaborated to propose the current version “Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)”. The IANR council board members and CANR committee members approved this proposal on September 1, 2016, and recommend it to clinical practitioners of cellular therapy. These guidelines include items of cell type nomenclature, cell quality control, minimal suggested cell doses, patient-informed consent, indications for undergoing cell therapy, contraindications for undergoing cell therapy, documentation of procedure and therapy, safety evaluation, efficacy evaluation, policy of repeated treatments, do not charge patients for unproven therapies, basic principles of cell therapy, and publishing responsibility.

KW - cell therapy

KW - clinical application guideline neurorestoratology

KW - neurorestoration

UR - http://www.scopus.com/inward/record.url?scp=85045446950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045446950&partnerID=8YFLogxK

U2 - 10.1177/0963689717746999

DO - 10.1177/0963689717746999

M3 - Article

C2 - 29637817

AN - SCOPUS:85045446950

VL - 27

SP - 310

EP - 324

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 2

ER -